ASAsim Sajjad

Asim Sajjad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asim Sajjad has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Trends in Alcohol–Related Deaths in the United States Over 55 Years: 1968–2023

    by Mohid Zulfiqar, Muhammad Salik Uddin, Faizan Abbas, Asim Sajjad, Ammad Uddin, Syed Ahmed Ali Shah, Gregg C. Fonarow, Saad Ahmed Waqas, Hermann Yokolo, Shaheer Qureshi

    Background: Alcohol consumption is a leading cause of preventable mortality worldwide. We examined long‐term trends in alcohol‐related deaths in the United States over 55 years (1968–2023) and analyzed demographic disparities. Methods: Using CDC WONDER data, we identified alcohol‐related deaths among adults aged ≥ 25 years. Age‐adjusted mortality rates (AAMRs) per 100,000 population were calculated, and joinpoint regression analyzed temporal trends by sex, race, age, and geographic region. Results: From 1968 to 2023, 1,321,804 alcohol‐related deaths occurred. AAMRs increased from 13.1 to 19.3 (AAPC: 0.7, p < 0.001), with a sharp acceleration during 2018–2021 (APC: 14.1) followed by a decline during 2021–2023 (APC: −6.9). Males consistently had higher mortality than females, though the gender gap narrowed. A striking racial inversion occurred: mortality among Black individuals declined from 27.7 to 13.5 (AAPC: −1.4), while mortality among White individuals increased from 11.3 to 21.1 (AAPC: 1.1) with older adults (65+) showing the steepest long‐term increase (AAPC: 1.4). Regionally, the Midwest experienced the greatest rise in mortality (AAPC: 1.4), while the Northeast remained stable. Conclusions: Alcohol‐related mortality has increased substantially over 55 years, with profound demographic shifts including a complete racial disparity inversion and narrowing gender gap. Recent declines (2021–2023) offer cautious optimism, but sustained, targeted interventions are needed for high‐risk populations.

  • Open Access

    Trends and Disparities in Atrial Fibrillation‐Related Mortality Among Older Adults With Parkinson's Disease in the United States, 2000–2023

    by Mohid Zulfiqar, Syed Ahmed Ali Shah, Asim Sajjad, Muhammad Tahir, Wasay Mumtaz Awan, Hermann Yokolo, Muhammad Ahmed

    Background: The coexistence of Parkinson's Disease (PD) and Atrial Fibrillation (AF) is increasingly recognized, but the mortality burden and disparities among affected individuals remain poorly characterized. Objective: This study aimed to analyze 24‐year trends, demographic patterns, and geographic disparities in AF‐related mortality among US older adults with PD. Methods: We conducted a population‐based analysis using CDC WONDER Multiple Cause of Death data from 2000 to 2023. Age‐adjusted mortality rates (AAMRs) were extracted for adults aged 65 and older with both AF and PD listed as causes of death. Trends were analyzed using Joinpoint regression to compute annual percentage changes (APCs). Results: Overall, AAMR increased from 3.1 in 2000 to 8.2 in 2023 per 100 000 population. A statistically significant acceleration occurred from 2015 to 2021 (APC: +10.7%; 95% CI: 7.8–13.8), followed by a non‐significant decline from 2021 to 2023 (APC: −2.7%; 95% CI: −10.3 to 5.5). Mortality was consistently higher among men than women throughout the study period. Non‐Hispanic White adults had the highest overall AAMR (5.6), while Hispanic adults demonstrated the most consistent upward trend (APC: +6.8%; 95% CI: 5.9–7.6). Pronounced geographic disparities were observed, with the highest mortality in the Western US and nonmetropolitan areas. State‐level AAMRs varied nearly fourfold, ranging from 7.7 in Minnesota to 2.0 in Nevada. Conclusion: AF‐related mortality among older adults with PD has risen substantially, marked by significant sex, racial, and geographic disparities. Future studies should conduct further investigation into the link between PD and AF.

  • Open Access

    Trends and Disparities in Atrial Fibrillation-Related Mortality Among Older Adults with Parkinson's Disease in the United States, 2000--2023

    by Mohid Zulfiqar, Syed Ahmed Ali Shah, Asim Sajjad, Muhammad Tahir, Wasay Mumtaz Awan, Muhammad Ahmed, Raheel Ahmed

    Background: The coexistence of parkinson’s disease (PD) and atrial fibrillation (AF) is increasingly recognized, but the mortality burden and disparities among affected individuals remain poorly characterized. Objective: This study aimed to analyze 24-year trends, demographic patterns, and geographic disparities in AF-related mortality among US older adults with PD. Methods: We conducted a population-based analysis using CDC WONDER Multiple Cause of Death data from 2000 to 2023. Age-adjusted mortality rates (AAMRs) were calculated for adults aged ≥65 with both AF and PD listed as causes of death. Trends were analyzed using Joinpoint regression to compute annual percentage changes (APCs). Results: AAMRs increased from 3.1 to 8.2 per 100,000, with a significant acceleration from 2015–2021 (APC: +10.7%) before declining. Mortality was consistently higher in men than women. Non-Hispanic White adults had the highest overall AAMR (5.6), while Hispanic adults exhibited the steepest upward trend (APC: +6.8%). Pronounced geographic disparities existed, with the highest mortality in the Western US and nonmetropolitan areas. State-level AAMRs varied nearly fourfold. Conclusion: AF-related mortality among older adults with PD has risen substantially, marked by significant sex, racial, and geographic disparities. These findings underscore the urgent need for targeted interventions and integrated care models to mitigate risks in this vulnerable population.

  • Open Access

    Trends and Disparities in Acute Myocardial Infarction‐Related Mortality Among U.S. Adults With Hypertension, 2000–2023

    by Maryam Sajid, Dua Ali, Shaheer Qureshi, Reja Ahmad, Asim Sajjad, Saad Ahmed Waqas, Raheel Ahmed, Peter Collins

    Background: Hypertension is a major public health concern and a key risk factor for acute myocardial infarction (AMI), significantly contributing to cardiovascular mortality. Despite advancements in management and treatment, trends in associated mortality remain underexplored.Objective: This study examines U.S. national trends in hypertension‐ and AMI‐associated mortality from 2000 to 2023, focusing on demographics and regions.Methods: Age‐adjusted mortality rates (AAMRs) per 100,000 for adults aged ≥ 25 with hypertension and AMI were extracted from the CDC WONDER database. Annual percent changes (APCs) and average APCs (AAPCs) with 95% confidence intervals (CIs) were calculated, stratified by year, sex, race/ethnicity, age, urbanization, and Census region.Results: From 2000 to 2023, 933,024 hypertension‐ and AMI‐related deaths were recorded. Overall, AAMR declined from 19.84 per 100,000 in 2000 to 16.26 in 2023 (AAPC: −0.93%, 95% CI: −1.18% to −0.76%). However, a sharp rise in mortality occurred between 2018 and 2021, coinciding with the COVID‐19 pandemic. Stratified analyses revealed persistently higher mortality rates among menmen, non‐Hispanic BlackBlack individuals, and residents of the Southern and rural U.S. regions. Younger adults showed an increasing AAMR trend, indicating a growing burden of hypertension and AMI‐associated disease.Conclusion: While long‐term mortality trends show a decline, recent years have seen a rise, particularly among high‐risk groups. Targeted public health interventions addressing hypertension management, cardiovascular risk reduction, and healthcare disparities are essential to mitigate the ongoing burden of hypertension and AMI mortality in the U.S.